Purification of Common Lung Cancer Antigen recognized with Monoclonal Antibody TFS and Production of Monoclonal Antibodies of Second Generation by its antigen.
Purification of Common Lung Cancer Antigen recognized with Monoclonal Antibody TFS and Production of Monoclonal Antibodies of Second Generation by its antigen.
批准号:
02670338
负责人:
FUJISAWA Michio
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Monoclonal antibody(MAb)TFS-2 was produced against Small Cell Lung Cancer and reacted with all tissue types of lung cancer. Recently we tried the radioimmunodetection of human lung cancer with ^<99m>Tc labeled TFS-2 followed by getting clear imaging of primary and metastatic lung cancers in the various tissues such as bone, lung, and liver.(1)Purification of Common Lung Cancer Antigen.Masses of metastatic small cell lung cancer to liver was used as source for purification. Samples were solubilized by PBS with 0.5% of NP-40. Samples were twice passed through Affinity Chromatography(tresyl-activated Sepharose 4B couppled with MAb TFS-2). NP-40 was removed by ethanol pi-ecipitatiori. SDS-PAGE showed 2 bands of protein, 39kDa and 33kDa respectedly. Band of 33 kDa reacted with MAb TFS-2 on the Western blotting. Protein of 33kDa was analyzed directly transferring to membrane and 20 amino acid residue was determined.(2)Analysis of Gene coding Common Lung Cancer Antigen.The MRNA was obtained from small cell lutig cancer cell line NCI-1169, and the expression CDNA library in plasmid was constructed from the MRNA. The plasmids were transfected to Cos-1 cells and clones expressing antigen on the cell surface were screened by ^<125>I labeled MAb TFS-2. A EDNA clone coding the protein reacted with MAb TFS-2 was isolated.(3)Production of Monoclonal antibodies of the second generation Several clones of hybridoma cell that reacted with purified antigen presently were obtained.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Yoshimi Umezawa.,et al: "Identity of Brain-Associated Small Cell Lung Cancer Antigen and the CD56(NKH/Leu-19) Leukocyte Differentiation Antigen and the Neural Cell Adhesion Molecule." Japanese Journal of Clinical Oncology. 21. 251-255 (1991)
Yoshimi Umezawa.,et al:“脑相关小细胞肺癌抗原和 CD56(NKH/Leu-19) 白细胞分化抗原和神经细胞粘附分子的身份。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y. Umezawa, S. Kuge, N, Kikyo, T. Shirai, J. Watanabe, M. Fujisawa, and T. Okabe: "Identity of Brain-associated Small Cell Lung Cancer Antigen and CD56 (NKH-1/Leu-19) leukocyte differenciation Antigen and the Neural Cell Adhesion Molecule." Jpn J Clin Onc
Y. Umezawa、S. Kuge、N、Kikyo、T. Shirai、J. Watanabe、M. Fujisawa 和 T. Okabe:“脑相关小细胞肺癌抗原和 CD56 (NKH-1/Leu-19) 的鉴定
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshimi Umezawa.,et al: "Identity of BrainーAssociated Small Cell Lung Cancer Antigen and the CD56(NKH/Leuー19)Leukocyte Differentiation Antigen and the Neural Cell Adhesion Molecule." Japanese Jounal of Clinical Oncology. 21. 251-255 (1991)
Yoshimi Umezawa.,et al:“脑相关小细胞肺癌抗原和 CD56(NKH/Leu-19)白细胞分化抗原和神经细胞粘附分子的鉴定。日本临床肿瘤学杂志”。 (1991)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者: